Journal Watch · Frontiers in Immunology · 2026

Characterization of lactylation-related subtypes and diagnostic markers in myocardial ischemic reperfusion injury using weighted gene coexpression network analysis and machine learning.

Notably, lactylation modifications may modulate immune responses and cellular signaling in MIRI, suggesting therapeutic relevance.<h4>Discussion</h4>In summary, this study identified seven robust diagnostic biomarkers for MIRI and demonstrated distinct molecular subtypes, offering key insights into its pathogenesis and providing a foundation for developing early diagnosis and personalized therapeutic strategies.

Bai J, Lu Y, Wei H et al.Frontiers in Immunology3 min readPharma relevance 50/100

DOI: 10.3389/fimmu.2026.1761225PMID: 42093976Study type: in-vitro / cell study

TL;DR

Notably, lactylation modifications may modulate immune responses and cellular signaling in MIRI, suggesting therapeutic relevance.<h4>Discussion</h4>In summary, this study identified seven robust diagnostic biomarkers for MIRI and demonstrated distinct molecular subtypes, offering key insights into its pathogenesis and providing a foundation for developing early diagnosis and personalized therapeutic strategies.

Key findings

  • Four of these genes (<i>G6pd</i>, <i>Itgb2</i>, <i>Pabpc1</i>, and <i>Runx2</i>) showed consistent expression in cell-based assays, supporting their biomarker potential.
  • Enrichment analysis revealed that these genes primarily clustered in cellular division, cytoskeletal reorganization, and multiple signaling pathways, highlighting their critical roles in myocardial injury.
  • Notably, lactylation modifications may modulate immune responses and cellular signaling in MIRI, suggesting therapeutic relevance.<h4>Discussion</h4>In summary, this study identified seven robust diagnostic biomarkers for MIRI and demonstrated distinct molecular subtypes, offering key insights into its pathogenesis and providing a foundation for developing early diagnosis and personalized therapeutic strategies.

What they did

Consensus clustering was used to classify MIRI into distinct subtypes, and machine learning models were developed for diagnostic purposes. Immune cell infiltration was evaluated using CIBERSORT. Key findings were validated via western blot, and an <i>in vitro</i> hypoxia -reoxygenation model of HL-1 cardiomyocytes was employed to verify gene expression patterns.<h4>Results</h4>We identified seven significantly expressed LRGs in MIRI: <i>G6pd</i>, <i>Tkt</i>, <i>Eif2s2</i>, <i>Pabpc1</i>, <i>Itgb2</i>, <i>Cenpf</i>, and <i>Runx2</i>.

Full abstract (original)

Background: <h4>Introduction</h4>Myocardial ischemia-reperfusion injury (MIRI) is a secondary injury that occurs after treatment for ischemic heart disease. This study aimed to identify key lactylation-related genes (LRGs) in MIRI to enable early diagnosis and reveal potential therapeutic targets for improved patient outcomes.<h4>Methods</h4>We analyzed MIRI gene expression datasets from the Gene Expression Omnibus database using differential gene expression and weighted gene coexpression network analyses to determine key genes and coexpression modules. LRGs from the GeneCards database were examined to reveal associations with MIRI.

What they did: Consensus clustering was used to classify MIRI into distinct subtypes, and machine learning models were developed for diagnostic purposes. Immune cell infiltration was evaluated using CIBERSORT. Key findings were validated via western blot, and an <i>in vitro</i> hypoxia -reoxygenation model of HL-1 cardiomyocytes was employed to verify gene expression patterns.<h4>Results</h4>We identified seven significantly expressed LRGs in MIRI: <i>G6pd</i>, <i>Tkt</i>, <i>Eif2s2</i>, <i>Pabpc1</i>, <i>Itgb2</i>, <i>Cenpf</i>, and <i>Runx2</i>.

Results & conclusions: Four of these genes (<i>G6pd</i>, <i>Itgb2</i>, <i>Pabpc1</i>, and <i>Runx2</i>) showed consistent expression in cell-based assays, supporting their biomarker potential. Enrichment analysis revealed that these genes primarily clustered in cellular division, cytoskeletal reorganization, and multiple signaling pathways, highlighting their critical roles in myocardial injury. Notably, lactylation modifications may modulate immune responses and cellular signaling in MIRI, suggesting therapeutic relevance.<h4>Discussion</h4>In summary, this study identified seven robust diagnostic biomarkers for MIRI and demonstrated distinct molecular subtypes, offering key insights into its pathogenesis and providing a foundation for developing early diagnosis and personalized therapeutic strategies.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1761225 · PubMed 42093976.

Why it matters for pharma & biotech

  • Directly relevant to teams in AI in drug discovery / diagnostics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: AI in drug discovery / diagnostics

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

Notably, lactylation modifications may modulate immune responses and cellular signaling in MIRI, suggesting therapeutic relevance.<h4>Discussion</h4>In summary, this study identified seven robust diagnostic biomarkers for MIRI and demonstrated distinct molecular subtypes, offering key insights into its pathogenesis and providing a foundation for developing early diagnosis and personalized therapeutic strategies.

What type of study is this?

It is a in-vitro / cell study, published in Frontiers in Immunology in 2026. Consensus clustering was used to classify MIRI into distinct subtypes, and machine learning models were developed for diagnostic purposes.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1761225. PubMed ID: 42093976. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Bai J, Lu Y, Wei H et al.. Characterization of lactylation-related subtypes and diagnostic markers in myocardial ischemic reperfusion injury using weighted gene coexpression network analysis and machine learning.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1761225.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/characterization-of-lactylation-related-subtypes-and-diagnostic-markers-761225/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides